The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine (Q28296512)

https://api.crossref.org/works/10.1007%2FBF02246164

Functional correlates of serotonin 5-HT1 recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246164

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246164

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246164

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246164

Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects

21 January 2018

1 reference

12 December 2020

5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus

1 reference

12 December 2020

Effects of chronic cocaine administration on the serotonergic system in the rat brain.

1 reference

12 December 2020

Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine

1 reference

12 December 2020

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder

1 reference

12 December 2020

Behavioral indications for serotonin receptor hypersensitivity in panic disorder.

1 reference

12 December 2020

Agonist-induced phosphoinositide hydrolysis in choroid plexus.

1 reference

12 December 2020

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)

1 reference

12 December 2020

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

12 December 2020

Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)

1 reference

12 December 2020

The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors

1 reference

12 December 2020

Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions.

1 reference

12 December 2020

m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia

1 reference

12 December 2020

Analysis of the 5-HT1C receptor and the serotonin uptake site in fawn-hooded rat brain.

1 reference

12 December 2020

Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats

1 reference

12 December 2020

The stimulus effects of serotonergic hallucinogens in animals

1 reference

12 December 2020

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

1 reference

12 December 2020

Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodone

1 reference

12 December 2020

Discriminative stimulus properties of m-chlorophenylpiperazine.

1 reference

12 December 2020

Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis

1 reference

12 December 2020

Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus

1 reference

12 December 2020

m-Chlorophenylpiperazine as a probe of serotonin function

1 reference

12 December 2020

Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors

1 reference

12 December 2020

Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats

1 reference

12 December 2020

Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.

1 reference

12 December 2020

Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents

1 reference

12 December 2020

(—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone

1 reference

12 December 2020

Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.

1 reference

12 December 2020

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 reference

12 December 2020

Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans

1 reference

12 December 2020

Structure and functional expression of cloned rat serotonin 5HT-2 receptor

1 reference

12 December 2020

Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat

1 reference

12 December 2020

The MCPP challenge test in schizophrenia: hormonal and behavioral responses

1 reference

12 December 2020

Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.

1 reference

12 December 2020

Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks.

1 reference

12 December 2020

Molecular characterization of a functional cDNA encoding the serotonin 1c receptor

1 reference

12 December 2020

Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.

1 reference

12 December 2020